JAK2 and COVID-19: The current treatments for COVID-19 encompass various therapeutic approaches, including nucleoside and nucleotide reverse transcriptase inhibitors, JAK1/JAK2 inhibitors, neutralizing monoclonal and polyclonal antibody therapies, as well as the administration of glucocorticosteroids such as dexamethasone and prednisone.